We demonstrated that FICD overexpression using transgenic FICD knock-in mice affected osteoclasts with no effect on disease activity, while inhibiting c-FMS signaling attenuated both disease activity and arthritic bone erosion in murine arthritis models. This evidence concerns the gene CSF1R and arthritic joint disease.